Dear Friends and Colleagues,
The Ι-th Kazakhstan International Congress on Bariatric and Metabolic Surgery to be hosted by the Society of Bariatric and Metabolic Surgeons of Kazakhstan. The acronym for the congress: KaSBariMeT-2018 (KazakhstanSurgicalBariatricMetabolicTreatment-2018).
KaSBariMeT-2018 is an international platform for presenting achievements on metabolic and bariatric surgery and related topics. This problem is first discussed in Central Asia. The purpose of the congress is the key lectures of leaders of bariatric and metabolic surgery and the exchanging of ideas about medical, social effects of bariatric metabolic surgery.
KaSBariMeT-2018 will promote the spread of knowledge in a large Euroasian region, where obesity and type 2 diabetes are rapidly expanding. The Congress will be a great contribution of participants for preventing problems caused by obesity for the benefit of society.
Place of congress - Astana city. Kazakhstan Astana’s favourable location in the centre of the Eurasian continent makes it an economically advantageous transport, communication and logistics centre, and a natural bridge between Europe and Asia.
Today Astana, located in the heart of Eurasia, is a venue for numerous international forums, congresses and large scale international events. The Congress of Leaders of World and Traditional Religions, the Astana Economic Forum and other forums are held regularly in the city. In December, 2010, the historical Summit of the Organisation for Security and Co-operation in Europe took place in the capital city of Kazakhstan, after which it hosted the anniversary summits of the Shanghai Cooperation Organisation and Organisation of Islamic Cooperation. In early 2011, the city welcomed the participants and guests of the 7th Asian Winter Games. In 2017, Astana hosted the international specialized exhibition EXPO-2017.
Welcome to the Congress «KaSBariMeT-2018» in Astana!
Henry Buchwald is Professor of Surgery and Biomedical Engineering and the Owen and Sarah Davidson Wangensteen Chair in Experimental Surgery Emeritus at the University of Minnesota, Minneapolis, Minnesota.
During his more than 50 years at the University of Minnesota, Buchwald has been a surgeon, teacher, mentor, researcher, and inventor. He is Professor of Surgery and Biomedical Engineering, Director of Graduate Surgical Training, Director of Resident Training, and Director of In-Training Examination. He was the first Owen H. and Sarah Davidson Wangensteen Chair in Experimental Surgery from 2001-2004 and holds the post as Emeritus. In 2002, the Minnesota Medical Alumni Society of the University of Minnesota presented him with the Harold S. Diehl Lifetime Achievement Award for Outstanding Professional Contributions.
His long-term research interests include cholesterol and atherosclerosis, obesity surgery, implantable devices, hyperlipidemias, and measurement of blood oxygen transport. Early in his career, he discovered that the part of the small intestine called the ileum is the primary site for the absorption or cholesterol and bile acids (the primary end-products of cholesterol metabolism), and, that performing surgery—Buchwald’s partial ileal bypass surgery—a procedure that bypasses part of the ileum, lowers cholesterol levels and dramatically improves the lives of those with familial hypercholesterolemia.
Buchwald trained with Richard Varco who performed the first obesity surgery in 1953. Since 1966, Buchwald has performed more than 4,000 obesity surgeries (also known as bariatric surgeries) and become one of the most influential and innovative surgeons in the field. As fellow bariatric surgeon Walter Pories said in a 2006 interview with Minnesota Monthly’s Tim Gihring, “If you named maybe 10 international leaders [in bariatric surgery] . . . Henry would fall on any list that people in the field would make.”
Throughout his career as a general surgeon, Buchwald has performed many thousands of surgeries, including all open gastrointestinal surgeries, partial ileal bypasses, jejunoileal bypasses, gastric bypasses, Fobi Pouch, vertical banded gastroplasty, roux-en-y bypasses, and duodenal switches.
His writing and influence also go into the realm of biomedical ethics and insurance reform. He has been president of the Central Surgical Association (1997–1998), the American Society of Bariatric Surgery (1998-1999), and the International Federation of Surgery for Obesity (2003-2004). He is coeditor of the journal, Obesity Surgery. He is a Fellow of the American Surgical Association, American College of Surgeons, Central Surgical Association, Cardiovascular Surgery Council and Epidemiology Council of the American Heart Association, and International College of Surgeons.
Declining opportunities to enter private practice, Buchwald has continued to devote tremendous energy towards mentoring younger surgeons. In 2002, the 53rd Volume of the Surgical Forum was dedicated to Buchwald. In the dedication to that issue, Marshall Z. Schwartz lists some of Henry Buchwald’s many accomplishments, commenting: “The above noted accomplishments and contributions alone warrant this dedication. But it has been Dr. Buchwald’s strong commitment to mentoring many young individuals (which he proudly lists in his curriculum vitae), including medical students, residents (both surgical and medical), and graduate students, that has made him a great academic role model. What makes Dr. Buchwald unique is his lifelong commitment to his trainees.”
Buchwald was still in his residency when he was granted his first research laboratory. At the time he was a Helen Hay Whitney Fellow. He studied histamine release, as well as groundbreaking work in lipids and the absorption of cholesterol. In 1973, The National Institute of Health (NIH) awarded Buchwald their largest investigator-initiated grant given to a principal investigator (one of the largest the University of Minnesota has ever received). The grant initiated the Program on the Surgical Control of the Hyperlipidemias (POSCH) trial. In 1990, the results of the first 17 years of this study were presented in the New England Journal of Medicine and at the annual meeting of the American College of Surgeons. The POSCH study definitely proved the link between cholesterol and heart disease. The POSCH trials demonstrated conclusively that lowering cholesterol can reduce heart disease and resultant heart attacks and, therefore, increase life expectancy. The results from all phases of the POSCH study have contributed significant insights and long-term data related to cholesterol, heart disease, and smoking. Buchwald has received seven additional NIH research grants. Buchwald, who has a joint appointment at the University of Minnesota in Biomedical Engineering, holds 17 patents for medical devices. These include the world’s first infusion port, peritoneovenous shunts, and specialty vascular catheters. He also invented the first implantable infusion pump, a precursor to implantable infusion pumps in use throughout the world today. He was inducted into the Minnesota Inventors Hall of Fame in 1988 for his extensive contributions to bioengineering devices.
In the late 1990s and early 2000s, Buchwald’s research has included: Type II diabetes and its reduction through bariatric surgery; oxygen transport and the development of a device to measure it; heart disease in women; and new technological approaches to bariatric surgery. One of his latest projects is the development of a new type of bariatric surgery called micro-orifice surgery, surgery performed open (as opposed to laparoscopically) but with very small incisions (to avoid complications of general anesthesia and make patients’ recovery faster and easier). His innovative research and development work continues.
Buchwald has authored or co-authored more than 300 peer-reviewed manuscripts. He is the co-editor, with Walford Gillison, of Pioneers in Surgical Gastroenterology (2007), as well as the co-author, with George S.M. Cowan and Walter J. Pories, of Surgical Management of Obesity (2006). His newest title, Buchwald Atlas of Metabolic and Bariatric Surgery Techniques and Procedures, was published in fall 2011.
He has been Section Editor of ASAIO Transactions, editor of Chirurgia Generale, and of the Journal of American College of Nutrition. He has been on the editorial board of The Journal of Clinical Surgery. Infu-Systems International, Diabetes, Nutrition, and Metabolism, Associate Editor, of Journal of Bariatric Surgery , Obesity Surgery and the Online Journal of Current Clinical Trials , and a consulting editor for Hospital Medicine.
Mazhit Zeynullovich Shaidarov — Doctor of medical science, professor, Honored worker of the Republic of Kazakhstan, Corresponding member of the National Academy of Science of the Republic of Kazakhstan.
Date of birth: 7 April, 1959, Tselinograd city.
Academic degree: doctor of medical science.
Academic rank: professor, corresponding member of NAS RK.
Work history is connected with JSC “Astana medical university” since 1976.
1976-1982 – Tselinograd state medical institute, student of the medical faculty;
1982-1984 – Tselinograd state medical institute, senior laboratory worker of the Chair of pharmacology;
1984-1992 – Tselinograd state medical institute, assistant of the Chair of pharmacology; 1992-1995 – State inflectional hospital, infectious disease physician, concurrently assistance of the Chair of pharmacology of TSMI;
1995-1997 – Tselinograd state medical institute, assistant professor of the Chair of general and clinical pharmacology;
1997- 2000 – City infectious hospital, chief physician, concurrently associate professor of the Chair of general and clinical pharmacology of TSMI;
2000-2006 – Healthcare department, Astana city, director;
2006-2009 – Healthcare department of Karaganda region, director;
2009-2010 – Committee for Control in the Sphere of Medical Services of MH RK in Astana, director, concurrently – professor of the Department of General and Clinical Pharmacology of JSC “Astana Medical University”;
Since 2010 up to the present – Rector-Chairman of the Board of JSC “Astana medical university”.
Academic degrees and ranks
1987 – defense of the candidate dissertation “Immunopharmacology of several psychotropic drugs” in the specialty 14.00.25 – “Pharmacology”;
2006 – defense of the doctoral dissertation “The main components of pharmacodynamics of original plant-based preparations with the potential of hepatoprotective activity” in the specialty 14.00.25 – “Pharmacology”;
2013 – academic rank of professor;
2016 – Academician of the European Academy of Natural Sciences Hannover (Germany); 2017 – corresponding member of the National Academy of Science of the Republic of Kazakhstan.
Professor Shaidarov published more than 138 scientific and methodological works including 105 scientific articles, 9 articles in international reviewed journals with non-zero impact-factor (according to the database of Thomson Reuter), 1 monography – “Pharmacodynamics of plant-based preparations with the potential of hepatoprotective activity”, Tomsk, 2006; 2 textbooks – “Basics of Pharmacology with Formulation”, Astana, 2011, 2014, 3 textbooks and guidance manuals, 2 drug handbooks, 1 guideline for the use in a clinic, 1 vocabulary-reference book (Latin-Russian-Kazakh).
- Deputy of Maslikhat of V and VI convocations in 4 election districts of Astana city; - Chairman of the Standing Committee for Social and Cultural Development of Astana; - Chairman of the Public Council for Combating Corruption in the Astana City Branch of “Nur Otan” party;
- Member of the commission under the faction of “Nur Otan” Party in Maslikhat of Astana to monitor the targeted and effective use of budget funds and funds allocated from the National Fund of the Republic of Kazakhstan for the implementation of the State Program for Infrastructure Development Nurly Zhol for 2015-2019.
M.Z. Shaidarov was awarded the honorary title of “Honoured worker of Kazakhstan” (2005), the order “Kurmet” (Honour) (2013), commemorative medals of the Republic of Kazakhstan, and the breastplate “For the excellent health worker of the Republic of Kazakhstan” (2002).
Professor Dr. Oral Ospanov — Head of the Department of Laparoscopic and Bariatric Surgery at Astana Medical University in Kazakhstan. He received a bachelor's degree and received Residency surgical training at Omsk Medical University in Russia.
In 2003 Doctor received a degree of a Doctor of Medical Science (DMedSc) and in 2008 a degree of a Professor of Medicine at Astana Medical University. In 2011, Prof. Dr. O.Ospanov founded the Association of Endoscopic Surgeons of Kazakhstan and since 2016 has been an honorary president of the society.
Since 2006 he has been involved in bariatric surgery. Prof. Dr. O.Ospanov is the founder of the first department of laparoscopic and bariatric surgery in Kazakhstan. He trained hundreds of surgeons of endoscopic surgery. Doctor is a pioneer of bariatric surgery in his country.
Prof. Dr. O.Ospanov is the founder (2014) and the first president of the Republican Public Association "Society of Bariatric and Metabolic Surgeons of Kazakhstan" (SBMSK). SBMSK is a member of the European chapters of IFSO. For pedagogical, scientific and surgical activities has government awards. Prof. Dr. O.Ospanov written more than 10 books on surgery. Currently he lives in the capital of Kazakhstan in the city of Astana.